Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Chenghua Luo"'
Autor:
Mengmeng Xiao, Da Qin, Xiangji Li, Fanqin Bu, Shixiang Ma, Xiaobing Chen, Yu Zhao, Chenghua Luo, Li Min
Publikováno v:
Clinical and Translational Medicine, Vol 14, Iss 10, Pp n/a-n/a (2024)
Externí odkaz:
https://doaj.org/article/8153b1c105054e71813d0a6c680ee5b1
Autor:
Yu Zhao, Da Qin, Xiangji Li, Tiange Wang, Tong Zhang, Xiaosong Rao, Li Min, Zhiyi Wan, Chenghua Luo, Mengmeng Xiao
Publikováno v:
Discover Oncology, Vol 15, Iss 1, Pp 1-9 (2024)
Abstract Background Retroperitoneal liposarcoma (RPLS) is known for its propensity for local recurrence and short survival time. We aimed to identify a credible and specific prognostic biomarker for RPLS. Methods Cases from The Cancer Genome Atlas (T
Externí odkaz:
https://doaj.org/article/cf80da0316ca4b52a0bf5f8f4a029e5c
Autor:
Jun Wang, Jun Chen, Kunpeng Liu, Hua Zhang, Yue Wei, Libin Suo, Shuang Lan, Yanzhen Wang, Chenghua Luo, Lan Yao
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
ObjectiveGiven high risks of major bleeding during retroperitoneal sarcoma(RPS) surgeries, severe complications and deaths are common to see perioperatively. Thus, effective anesthetic management is the key point to ensuring the safety of patients. T
Externí odkaz:
https://doaj.org/article/6a3c63d6a9114cd49b8c510b00703b95
Publikováno v:
Chinese Medical Journal, Vol 136, Iss 17, Pp 2113-2115 (2023)
Externí odkaz:
https://doaj.org/article/d483b02575154d7c84de4be04ff6cf6b
Publikováno v:
BMC Surgery, Vol 23, Iss 1, Pp 1-7 (2023)
Abstract Background Aggressive angiomyxoma (AAM) is a rare mesenchymal tumor that mostly arises from the pelvic and perineal soft tissues. Few studies reported its characteristics and outcomes previously due to its rarity and challenges of treatments
Externí odkaz:
https://doaj.org/article/4f3580ae339e495cbd692237341c59bc
Autor:
Kaige Yang, Yufang Xie, Lele Xue, Fanping Li, Chenghua Luo, Weihua Liang, Haijun Zhang, Ya Li, Yilin Ren, Mengmeng Zhao, Weinan Wang, Jia Liu, Xihua Shen, Wenhu Zhou, Jing Fei, Weigang Chen, Wenyi Gu, Lianghai Wang, Feng Li, Jianming Hu
Publikováno v:
Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-19 (2023)
Abstract Background Esophageal squamous cell carcinoma (ESCC) is a deadly gastrointestinal malignancy, and chemotherapy resistance is a key factor leading to its poor prognosis. M2 tumor-associated macrophages (M2-TAMs) may be an important cause of c
Externí odkaz:
https://doaj.org/article/9f7e290aa6244533b781657aa07f6502
Publikováno v:
Radiation Oncology, Vol 17, Iss 1, Pp 1-11 (2022)
Abstract Background Neoadjuvant radiotherapy (NRT) for resectable retroperitoneal sarcoma (RPS) has been shown to be systematically feasible. Whether NRT has equivalent or better clinical effects compared to surgery alone for RPS patients remains con
Externí odkaz:
https://doaj.org/article/098de087ced543178764123b9b4c539a
Autor:
Xiangji Li, Fanqin Bu, Shixiang Ma, Ferdinando Cananzi, Yu Zhao, Mengmeng Xiao, Li Min, Chenghua Luo
Publikováno v:
Cell Communication and Signaling, Vol 20, Iss 1, Pp 1-15 (2022)
Abstract Background Retroperitoneal liposarcoma (RPLS) is a specific soft tissue sarcoma with a high recurrence rate. The short isoform of transient receptor potential cation channel subfamily M member 2 (TRPM2-S) plays an important role in the regul
Externí odkaz:
https://doaj.org/article/e1ad37bd76a145a9b06b7c84f5c94b41
Publikováno v:
Radiation Oncology, Vol 16, Iss 1, Pp 1-11 (2021)
Abstract Background Adjuvant therapy is a promising treatment to improve the prognosis of cancer patients, however, the evidence base driving recommendations for adjuvant radiotherapy (ART) or chemotherapy (ACT) in retroperitoneal sarcomas (RPS) prim
Externí odkaz:
https://doaj.org/article/4276763c60314426bda81348ecbb348e
Autor:
Fu'an Xie, Dongmei Qin, Lanlan Lian, Ming Li, Xu Kong, Xiaogang Xia, Chundong Yu, Chenghua Luo, Wengang Li
Publikováno v:
Cancer Communications, Vol 41, Iss 7, Pp 631-634 (2021)
Externí odkaz:
https://doaj.org/article/c3eae2ff7f6b41afa119a293748cb3c8